SRRK - Scholar Rock Holding Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Cambridge,
United States
Type: Equity
SRRK price evolution
SRRK
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $95.78 | $94.39 | $104.26 | |
| Short term investments | $97.12 | $146.45 | $178.08 | |
| Net receivables | $1.12 | |||
| Inventory | ||||
| Total current assets | $152.93 | $199.14 | $246.93 | $288.19 |
| Long term investments | ||||
| Property, plant & equipment | $19.99 | $21.52 | $13.84 | $16.02 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $27.73 | $20.35 | $22.84 | |
| Total investments | $97.12 | $146.45 | $178.08 | |
| Total assets | $179.13 | $226.87 | $267.29 | $311.04 |
| Current liabilities | ||||
| Accounts payable | $4.07 | $3.31 | $2.87 | $3.46 |
| Deferred revenue | ||||
| Short long term debt | $7.79 | $13.12 | $8.74 | |
| Total current liabilities | $39.37 | $32.99 | $37.51 | $32.74 |
| Long term debt | $50.1 | $60.26 | $47.01 | $53.08 |
| Total noncurrent liabilities | $60.26 | $47.01 | $53.08 | |
| Total debt | $68.04 | $60.13 | $61.82 | |
| Total liabilities | $99.94 | $93.25 | $84.51 | $85.82 |
| Shareholders' equity | ||||
| Retained earnings | -$856.26 | -$791.78 | -$733.27 | -$676.42 |
| Other shareholder equity | $0.13 | -$0.05 | -$0.05 | $0.09 |
| Total shareholder equity | $133.62 | $182.77 | $225.22 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $104.26 | $105.77 | $215.33 | $162.86 |
| Short term investments | $178.08 | $212.09 | $40.16 | $180.67 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $288.19 | $328.02 | $265.32 | $344.4 |
| Long term investments | ||||
| Property, plant & equipment | $16.02 | $25.93 | $35.01 | $40.38 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.84 | $30.14 | $39.13 | $43.9 |
| Total investments | $178.08 | $212.09 | $40.16 | $180.67 |
| Total assets | $311.04 | $358.17 | $304.44 | $388.31 |
| Current liabilities | ||||
| Accounts payable | $3.46 | $3.99 | $4.43 | $3.41 |
| Deferred revenue | $33.19 | $52.01 | ||
| Short long term debt | $8.74 | $7.85 | $8.98 | $5.37 |
| Total current liabilities | $32.74 | $36.39 | $64.3 | $42.56 |
| Long term debt | $53.08 | $49.74 | $68.07 | $51.77 |
| Total noncurrent liabilities | $53.08 | $61.54 | $68.07 | $84.97 |
| Total debt | $61.82 | $69.4 | $77.06 | $57.14 |
| Total liabilities | $85.82 | $97.93 | $132.37 | $127.53 |
| Shareholders' equity | ||||
| Retained earnings | -$676.42 | -$510.63 | -$376.13 | -$244.33 |
| Other shareholder equity | $0.09 | -$0.88 | -$0.04 | -$0 |
| Total shareholder equity | $225.22 | $260.24 | $172.07 | $260.77 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $42.37 | $43.09 | $34.96 | |
| Selling, general & administrative | $17.13 | $15.32 | $13.07 | |
| Total operating expenses | $59.5 | $58.42 | $48.03 | |
| Operating income | -$59.5 | -$58.42 | -$48.03 | |
| Income from continuing operations | ||||
| EBIT | -$58.51 | -$56.85 | -$46.13 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$58.51 | -$56.85 | -$46.13 | |
| Income (for common shares) | -$58.51 | -$56.85 | -$46.13 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $33.19 | $18.82 | $15.4 | |
| Cost of revenue | ||||
| Gross Profit | $33.19 | $18.82 | $15.4 | |
| Operating activities | ||||
| Research & development | $121.9 | $124.44 | $108.47 | $74.06 |
| Selling, general & administrative | $49.4 | $43.12 | $40.27 | $28.22 |
| Total operating expenses | $171.29 | $167.56 | $148.74 | $102.28 |
| Operating income | -$171.29 | -$134.37 | -$129.92 | -$86.88 |
| Income from continuing operations | ||||
| EBIT | -$165.79 | -$134.5 | -$131.8 | -$86.48 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$165.79 | -$134.5 | -$131.8 | -$86.48 |
| Income (for common shares) | -$165.79 | -$134.5 | -$131.8 | -$86.48 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$58.51 | -$56.85 | -$46.13 | |
| Operating activities | ||||
| Depreciation | $1.78 | $2.21 | $2.25 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.31 | $8.16 | $6.95 | |
| Total cash flows from operations | -$49.2 | -$49.78 | -$37.35 | |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.02 | ||
| Investments | $50.64 | $33.41 | -$25.13 | |
| Total cash flows from investing | $119.31 | $50.62 | $33.38 | -$25.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.05 | $6.53 | $96.53 | |
| Net borrowings | -$0.08 | |||
| Total cash flows from financing | $6.66 | -$0.03 | $6.53 | $96.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$25.46 | $1.39 | -$9.88 | $34.05 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$165.79 | -$134.5 | -$131.8 | -$86.48 |
| Operating activities | ||||
| Depreciation | $9.97 | $9.88 | $9.02 | $3.87 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $27.14 | $27.7 | $23.15 | $11.18 |
| Total cash flows from operations | -$145.23 | -$132.69 | -$126.79 | -$60.27 |
| Investing activities | ||||
| Capital expenditures | -$0.06 | -$1.06 | -$5.25 | -$4.09 |
| Investments | $41.2 | -$170.63 | $139.56 | -$59.41 |
| Total cash flows from investing | $41.14 | -$171.7 | $134.31 | -$63.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $102.57 | $195.81 | $19.99 | $223.22 |
| Net borrowings | -$0.97 | $24.98 | $24.62 | |
| Total cash flows from financing | $102.57 | $194.83 | $44.95 | $247.82 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.51 | -$109.56 | $52.48 | $124.05 |
News
Fundamentals
| Market cap | $3.02B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 80.08M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.38 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.88 |
| Quick ratio | N/A |